Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-067116
Filing Date
2017-12-22
Accepted
2017-12-22 17:15:27
Documents
1
Period of Report
2017-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3408
  Complete submission text file 0001209191-17-067116.txt   4764
Mailing Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025
Business Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025 6509638580
Versartis, Inc. (Issuer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERSARTIS, INC. 275 SHORELINE DRIVE, SUITE 450 REDWOOD CITY CA 94065
Business Address
Westberg Paul (Reporting) CIK: 0001601949 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36361 | Film No.: 171273301